References
Nazir S, Lohani S, Tachamo N, Poudel D, Donato A (2017) Statin-associated autoimmune myopathy: a systematic review of 100 cases. J Clin Rheumatol 23:149–154
Carroll MB, Newkirk MR, Sumner NS (2016) Necrotizing autoimmune myopathy: a unique subset of idiopathic inflammatory myopathy. J Clin Rheumatol Pract Rep Rheum Musculoscelet Dis 22:376–380
Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL (2010) A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum 62:2757–2766
Argov Z (2015) Statins and the neuromuscular system: a neurologist’s perspective. Eur J Neurol 22:31–36
Allenbach Y, Drouot L, Rigolet A, Charuel JL, Jouen F et al (2014) French myositis network: anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin. Medicine (Baltim) 93:150–157
Acknowledgements
We thank Prof. Martina Deckert for critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest regarding this article.
Ethical approval
This article does not contain any studies with human participants performed by any of the authors.
Informed consent
Informed consent was obtained from the patient included in the study.
Rights and permissions
About this article
Cite this article
Balke, M., Brunn, A., Claeys, K.G. et al. Late onset necrotizing autoimmune myopathy 1 year after cessation of statin treatment. Acta Neurol Belg 119, 487–489 (2019). https://doi.org/10.1007/s13760-018-0985-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-018-0985-x